Reporting Manager
Madison Avenue Partners, LP
Symbol
OVID
Shares outstanding
71,308,800 shares
Disclosed Ownership
2,852,352 shares
Ownership
4%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:41:31 UTC
Date of event
31 Dec 2024

Sponsored

Quoteable Key Fact

"Madison Avenue Partners, LP disclosed 4% ownership in Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID) on 31 Dec 2024."

Quick Takeaways

  • Madison Avenue Partners, LP filed SCHEDULE 13G/A for Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") (OVID).
  • Disclosed ownership: 4%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 17:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue Partners, LP 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC the General Partner of Madison Avenue Partners, LP
Madison Avenue International LP 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
EMAI Management, LLC 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 4% 2,852,352 0 2,852,352 /s/ Eli Samaha Eli Samaha